|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
106.75(B) |
Last
Volume: |
6,978,222 |
Avg
Vol: |
8,439,653 |
52
Week Range: |
$48.64 - $74.55 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 297 |
Guru Rank Value : 4.1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
131,028 |
294,034 |
784,747 |
1,896,260 |
Total Sell Value |
$9,081,880 |
$18,529,068 |
$44,400,077 |
$93,901,157 |
Total People Sold |
8 |
9 |
11 |
13 |
Total Sell Transactions |
13 |
22 |
38 |
73 |
End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Brennan Daniel J. |
EVP and CFO |
|
2023-02-15 |
4 |
OE |
$0.00 |
$55,957 |
D/D |
11,725 |
285,107 |
|
- |
|
Brown Vance R |
SVP, GC and Corp. Secretary |
|
2023-02-15 |
4 |
D |
$47.29 |
$15,275 |
D/D |
(323) |
38,602 |
|
- |
|
Brown Vance R |
SVP, GC and Corp. Secretary |
|
2023-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
923 |
38,925 |
|
- |
|
Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
|
2023-02-15 |
4 |
D |
$47.29 |
$38,731 |
D/D |
(819) |
24,419 |
|
- |
|
Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
|
2023-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,846 |
25,238 |
|
- |
|
Monson Jonathan |
SVP, Global Controller and CAO |
|
2023-02-15 |
4 |
D |
$47.29 |
$16,079 |
D/D |
(340) |
33,001 |
|
- |
|
Monson Jonathan |
SVP, Global Controller and CAO |
|
2023-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
739 |
33,341 |
|
- |
|
Sorenson John Bradley |
EVP, Global Operations |
|
2023-02-15 |
4 |
D |
$47.29 |
$25,915 |
D/D |
(548) |
35,659 |
|
- |
|
Sorenson John Bradley |
EVP, Global Operations |
|
2023-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,200 |
36,207 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2023-02-15 |
4 |
D |
$47.29 |
$29,414 |
D/D |
(622) |
89,888 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2023-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,031 |
90,510 |
|
- |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2023-02-15 |
4 |
D |
$47.29 |
$387,116 |
D/D |
(8,186) |
1,813,151 |
|
- |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2023-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,457 |
1,821,337 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2023-02-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
11,000 |
209,827 |
|
- |
|
Carruthers Wendy |
EVP, Human Resources |
|
2023-02-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,195 |
88,685 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2023-02-09 |
4 |
GA |
$0.00 |
$0 |
I/I |
630 |
4,344 |
|
- |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2023-02-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,520 |
220,827 |
|
- |
|
Sorenson John Bradley |
EVP, Global Operations |
|
2023-02-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,779 |
35,007 |
|
- |
|
Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
|
2023-02-03 |
4 |
S |
$48.74 |
$1,316,037 |
D/D |
(27,000) |
23,392 |
|
-10% |
|
Butcher Arthur C |
EVP& Grp Pres, MedSurg & APAC |
|
2023-02-03 |
4 |
OE |
$16.31 |
$249,206 |
D/D |
15,034 |
50,392 |
|
- |
|
Dockendorff Charles J |
Director |
|
2023-01-06 |
4 |
GD |
$0.00 |
$0 |
I/I |
8,201 |
0 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2023-01-04 |
4 |
AS |
$46.38 |
$313,123 |
D/D |
(6,751) |
88,479 |
|
15% |
|
Thepaut Eric Francis Yves |
EVP & Pres, Eur, Mid-East, Afr |
|
2023-01-01 |
4 |
D |
$46.27 |
$184,525 |
D/D |
(3,988) |
60,638 |
|
- |
|
Thepaut Eric Francis Yves |
EVP & Pres, Eur, Mid-East, Afr |
|
2023-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,092 |
64,626 |
|
- |
|
Sorenson John Bradley |
EVP, Global Operations |
|
2023-01-01 |
4 |
D |
$46.27 |
$67,693 |
D/D |
(1,463) |
39,786 |
|
- |
|
4527 Records found
|
|
Page 14 of 182 |
|
|